MedTrace Logo

Immunological Parameters Between MRONJ Stages

NCT06420284 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 42

Last updated 2024-05-20

No results posted yet for this study

Summary

This study aims to conduct a detailed analysis of the immunological response profiles that emerge at different clinical stages of medication-related osteonecrosis of the jaw (MRONJ). The research seeks to understand how these responses influence the pathogenesis, staging, and treatment of MRONJ. Throughout the study, cytokine levels, inflammation markers, and other immunological parameters observed at various stages will be comprehensively assessed. The results of these analyses are expected to provide insights into how stage-specific immunological variables could play a role in the diagnosis and treatment of MRONJ.

Conditions

  • Medication-Related Osteonecrosis of Jaw

Sponsors & Collaborators

  • Marmara University

    lead OTHER

Principal Investigators

  • Ferit Bayram, PhD · Marmara University Faculty of Dentistry

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-05-01
Primary Completion
2025-02-01
Completion
2025-05-01

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06420284 on ClinicalTrials.gov